| Observational Study on Levemir® in Obese Diabetic Patients (NCT00849342) | Novo Nordisk A/S | 2008-12-01 |
| Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus (NCT00814294) | Diasome Pharmaceuticals | 2008-12-01 |
| Case-Control Study of Inflammatory Breast Cancer in North Africa (NCT00793390) | National Cancer Institute (NCI) | 2008-11-17 |
| A Survey on the Rate of Glucose Intolerance in Hong Kong Chinese (NCT00787215) | Chinese University of Hong Kong | 2008-11-01 |
| Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus (NCT00806858) | Novo Nordisk A/S | 2008-11-01 |
| Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication (NCT00869908) | Novo Nordisk A/S | 2008-11-01 |
| Risk Factors for Implant Bone Loss in Patients With Diabetes Mellitus (NCT00933491) | University of Michigan | 2008-11-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Indonesia (NCT00788853) | Novo Nordisk A/S | 2008-11-01 |
| Effect of a Treatment of Lifestyle Changes on the Prevalence of Metabolic Syndrome and Body Weight in Mexican Women (NCT02247635) | Mexican National Institute of Public Health | 2008-11-01 |
| Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes. (NCT00793273) | Novo Nordisk A/S | 2008-11-01 |
| Insulin Balanced Infusion System (NCT01291719) | Admetsys Corporation | 2008-11-01 |
| Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes (NCT00789191) | Novo Nordisk A/S | 2008-11-01 |
| Evaluation of the A1CNow+ Test Kit (NCT00798486) | Ascensia Diabetes Care | 2008-11-01 |
| Improving Health Habits in Impoverished Populations (NCT00569595) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2008-11-01 |
| Examining the Effects of Antipsychotic Medications on Insulin Sensitivity (NCT00895921) | Veterans Medical Research Foundation | 2008-11-01 |
| Effects of Heating Massaging Vibrating Vicinity of the Insulin Delivery Site (NCT01307514) | Hadassah Medical Organization | 2008-11-01 |
| An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes (NCT00789711) | Novo Nordisk A/S | 2008-11-01 |
| Individual Differences in Diabetes Risk: Role of Slow WaveSleep (NCT00989378) | University of Chicago | 2008-11-01 |
| Emory Latino Diabetes Education Program (NCT00793884) | Emory University | 2008-10-01 |
| Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin (NCT00775736) | Novo Nordisk A/S | 2008-10-01 |
| Androgen Deprivation Therapy Study (NCT00743327) | National Institute on Aging (NIA) | 2008-10-01 |
| Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes (NCT00771680) | Novo Nordisk A/S | 2008-10-01 |
| Enhancing Fitness in Older Pre-diabetic Veterans (NCT00594399) | US Department of Veterans Affairs | 2008-10-01 |
| Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers (NCT00804414) | Biotec Pharmacon ASA | 2008-10-01 |
| To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo (NCT00761540) | Novo Nordisk A/S | 2008-10-01 |
| Cardiovascular Health And Risk Modification in Family Health Teams (NCT00787306) | University of Toronto | 2008-10-01 |
| Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes (NCT00770367) | Medical University of South Carolina | 2008-10-01 |
| Observational Study on Safety of Self-titration of Once Daily Levemir® (NCT00740519) | Novo Nordisk A/S | 2008-09-01 |
| Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics (NCT00773279) | Novo Nordisk A/S | 2008-09-01 |
| Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients (NCT00745914) | The University of Hong Kong | 2008-09-01 |
| Effect of Ezetimibe on Oxidized Low-density Lipoprotein (LDL) Cholesterol (NCT01008345) | Hotel Dieu de France Hospital | 2008-09-01 |
| The GoodNEWS Lifestyle Enhancement Program (NCT00669630) | University of Texas Southwestern Medical Center | 2008-09-01 |
| Effects of Antioxidants and B Vitamins Supplements on Inflammation in Obese Diabetic Patients (NCT01691365) | United Arab Emirates University | 2008-09-01 |
| Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months (NCT00755833) | Novo Nordisk A/S | 2008-09-01 |
| Northern Manhattan Diabetes Community Outreach Project (NCT00787475) | Columbia University | 2008-09-01 |
| Adherence and Intensification of Medications (AIM) Implementation Study (NCT00495794) | US Department of Veterans Affairs | 2008-08-01 |
| Improving Diabetes Care With Patient Decision Aids - A Trial in Community-based Primary Care (NCT00668590) | University of California, Los Angeles | 2008-08-01 |
| Diabetes in the Perioperative Period (NCT00738114) | Emory University | 2008-08-01 |
| Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults (NCT00737633) | VIVUS LLC | 2008-08-01 |
| Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan (NCT00766441) | University of Manchester | 2008-08-01 |
| Treat Arterial Hypertension and Diabetes in Rural Africa (NCT00744458) | Cooperation Afrique | 2008-08-01 |
| Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics (NCT00752180) | Wockhardt | 2008-08-01 |
| Systemic Effects of Epidural Methylprednisolone Injection on Glucose Tolerance in Diabetic Patients (NCT01420497) | Centre Hospitalier Universitaire Vaudois | 2008-08-01 |
| Modeling the Epidemiologic Transition Study (NCT02925156) | Loyola University | 2008-07-16 |
| Self-Management in African Americans With Diabetes and Hypertension (NCT01244152) | Rush University Medical Center | 2008-07-01 |
| PIoglitazone for PrEvention of Restenosis in Diabetic Patients (NCT00376870) | University of Rome Tor Vergata | 2008-07-01 |
| Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension (NCT00795262) | InVasc Therapeutics, Inc. | 2008-07-01 |
| Partnership for a Hispanic Diabetes Prevention Program (NCT01564797) | Fred Hutchinson Cancer Center | 2008-07-01 |
| ST of TN-Salud Con La Familia: Prevent Onset of Ped Obesity (NCT00808431) | Vanderbilt University | 2008-07-01 |
| Multi-arm Intervention Diabetes Adherence Study (NCT00754741) | Henry Ford Health System | 2008-07-01 |
| Evaluation of a Diabetes Data Management System (NCT00694070) | Ascensia Diabetes Care | 2008-07-01 |
| Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4 (NCT00910130) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2008-07-01 |
| First in Man Study With SLV341 (NCT00887445) | Solvay Pharmaceuticals | 2008-07-01 |
| Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics (NCT00697450) | Novo Nordisk A/S | 2008-07-01 |
| Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects. (NCT00719108) | Wockhardt | 2008-07-01 |
| Taste Perception and Chronic Disease Risk (NCT01023906) | Tufts University | 2008-07-01 |
| Microcirculation Assessment in Diabetes and Metabolic Syndrome (NCT01014949) | S.M. Misericordia Hospital | 2008-07-01 |
| Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome (NCT01564485) | University of California, Irvine | 2008-07-01 |
| A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide (NCT00696657) | Novo Nordisk A/S | 2008-06-03 |
| An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes (NCT00738153) | Novo Nordisk A/S | 2008-06-01 |
| Continuous Glucose Monitoring in Critically Ill (NCT00707434) | M.D. Anderson Cancer Center | 2008-06-01 |
| PAR Regulation of Platelet Function in Diabetic Patients (NCT00855374) | Vanderbilt University | 2008-06-01 |
| Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes (NCT01464099) | Novo Nordisk A/S | 2008-06-01 |
| Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes (NCT00698802) | Novo Nordisk A/S | 2008-06-01 |
| Effects of Statins on Lower Extremity Arterial Function Assessed by Magnetic Resonance Imaging (NCT00770679) | Johns Hopkins University | 2008-06-01 |
| Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes (NCT00699179) | Novo Nordisk A/S | 2008-06-01 |
| The Healthy Options Feasibility Study (NCT00746460) | McGill University | 2008-06-01 |
| Addressing The Role of Nutrition Education & Health Literacy in Diabetes Care (NCT00715585) | Vanderbilt University | 2008-06-01 |
| Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes (NCT00847262) | Third Military Medical University | 2008-06-01 |
| Disaster Preparedness Among Families Caring for Children With Diabetes (NCT00781313) | Baylor College of Medicine | 2008-06-01 |
| Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents (NCT00715780) | Novo Nordisk A/S | 2008-06-01 |
| Mobile Diabetes Management (NCT01107015) | University of Maryland, Baltimore | 2008-06-01 |
| The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus (NCT00700817) | Novo Nordisk A/S | 2008-06-01 |
| Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects (NCT01868581) | Novo Nordisk A/S | 2008-05-01 |
| The FLAVO Trial: Dietary Flavonoids and Cardiovascular Disease Risk Reduction in Postmenopausal Women With Type 2 Diabetes (NCT00677599) | University of East Anglia | 2008-05-01 |
| I Am Able: Population Based Rehabilitation in a Family Health Team (NCT00859638) | Hamilton Health Sciences Corporation | 2008-05-01 |
| Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes (NCT00737776) | Novo Nordisk A/S | 2008-05-01 |
| Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes (NCT00704223) | Novo Nordisk A/S | 2008-05-01 |
| Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus (NCT00709475) | Novo Nordisk A/S | 2008-05-01 |
| Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30 (NCT00675493) | Novo Nordisk A/S | 2008-05-01 |
| Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen® (NCT00709683) | Novo Nordisk A/S | 2008-05-01 |
| Tailored Case Management for Diabetes and Hypertension (NCT00978835) | Duke University | 2008-05-01 |
| Caloric Restriction, Exercise, and Glucoregulation in Humans (NCT00777621) | St. Louis University | 2008-04-01 |
| Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance (NCT00663000) | University Hospital Tuebingen | 2008-04-01 |
| Clarksdale Diabetes and Metabolism Clinic CHEC Study (NCT00791453) | University of Mississippi Medical Center | 2008-04-01 |
| Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes (NCT00687063) | Novo Nordisk A/S | 2008-04-01 |
| Pioglitazone on Cardiac Function and Large Arteries (PICCOLA Study) (NCT00485056) | Imperial College London | 2008-04-01 |
| Nutritional, Metabolic and Respiratory Status in Cystic Fibrosis (NCT00476281) | University Hospital, Strasbourg, France | 2008-04-01 |
| Insulin Secretion in Diabetes Before and After Glycemic Control (NCT00469833) | US Department of Veterans Affairs | 2008-04-01 |
| Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes (NCT00825643) | Novo Nordisk A/S | 2008-04-01 |
| IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients (NCT00567398) | Vantive Health LLC | 2008-04-01 |
| The Medication Adherence Program (NCT00838344) | University of Washington | 2008-04-01 |
| Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes (NCT00696163) | Novo Nordisk A/S | 2008-04-01 |
| Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes (NCT01868568) | Novo Nordisk A/S | 2008-04-01 |
| OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment. (NCT00681850) | AstraZeneca | 2008-03-01 |
| Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes (NCT00735501) | Novo Nordisk A/S | 2008-03-01 |
| Clinical Decision Support Consortium (NCT00853619) | Brigham and Women's Hospital | 2008-03-01 |
| Glycemic Responses and Sensory Characteristics of Whole Yellow Pea Flour Added to Novel Functional Foods (NCT00877968) | University of Manitoba | 2008-03-01 |
| Improving Diabetes After Bariatric Surgery (NCT00676923) | University of Pittsburgh | 2008-03-01 |
| An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised Subjects (NCT00700648) | Novo Nordisk A/S | 2008-03-01 |